This article was first published 22 years ago

Alembic launches Cepime

Share:

January 28, 2003 12:18 IST

Alembic Ltd has launched a 4th Generation Injectable Cephalosporin Cefepime under the brand name of Cepime. Cepime is the only US FDA approved 4th generation Cephalosporin, and its spectrum of activity is far superior to the existing 3rd generation Cephalosporin injections like Ceftazidime, Ceftriaxone and Cefotaxime.

BSE Code: 506235

Share:

Moneywiz Live!